Fetterman will 'be back soon,' comms director says



Democratic Sen. John Fetterman of Pennsylvania, who checked into Walter Reed National Military Medical Center more than a month ago due to clinical depression, will return "soon," according to communications director Joe Calvello.

"He'll be back soon, at least over a week, but soon," Joe Calvello noted Thursday, according to the Associated Press.

Calvello said the lawmaker is getting daily in-person briefings from chief of staff Adam Jentleson, according to the outlet.

"While John has experienced depression off and on throughout his life, it only became severe in recent weeks," a statement released last month by Jentleson said. "On Monday, John was evaluated by Dr. Brian P. Monahan, the Attending Physician of the United States Congress. Yesterday, Dr. Monahan recommended inpatient care at Walter Reed. John agreed, and he is receiving treatment on a voluntary basis," the statement noted at the time.

Earlier in February, Fetterman had been taken to George Washington University Hospital after experiencing lightheadedness, but he was released later the same week. "In addition to the CT, CTA, and MRI tests ruling out a stroke, his EEG test results came back normal, with no evidence of seizures," a statement released at the time by Calvello noted.

The left-wing politician had a pacemaker with a defibrillator implanted last year after suffering a stroke — he has been having problems with auditory processing in the wake of the stroke.

He took office earlier this year after defeating Republican candidate Dr. Mehmet Oz in the Keystone State's 2022 U.S. Senate race.

Earlier this month, Jentleson indicated that Fetterman was "well on his way to recovery."

"Society's expectations and traditional gender roles play a part in why men are less likely to discuss or seek help for their mental health. As always, John continues to challenge the conversation. So human, so kind, so cute," Fetterman's wife Gisele tweeted.

None
— (@)

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!